Eisai
4523.T
#2332
Rank
โ‚น787.62 B
Marketcap
โ‚น2,791
Share price
0.23%
Change (1 day)
13.11%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): โ‚น73.02

According to Eisai's latest financial reports the company's current EPS (TTM) is โ‚น83.08. In 2026 the company made an earnings per share (EPS) of โ‚น82.72 a decrease over its 2025 EPS that were of โ‚น104.76.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026โ‚น82.72-21.04%
2025โ‚น104.7611.85%
2024โ‚น93.66-32.63%
2023โ‚น139.025.52%
2022โ‚น131.75-74.01%
2021โ‚น506.87-66.58%
2020โ‚น1,51698.24%
2019โ‚น764.9517.01%
2018โ‚น653.7437.78%
2017โ‚น474.50-27.62%
2016โ‚น655.5835.33%
2015โ‚น484.43-2.82%
2014โ‚น498.50-27.66%
2013โ‚น689.15-27.49%
2012โ‚น950.46-12.67%
2011โ‚น1,08888.08%
2010โ‚น578.69-11.06%
2009โ‚น650.67-390.15%
2008-โ‚น224.26-127.78%
2007โ‚น807.36347.11%
2006โ‚น180.574.38%
2005โ‚น173.007.4%
2004โ‚น161.0943.03%
2003โ‚น112.6325.09%
2002โ‚น90.0452.67%
2001โ‚น58.9769.76%
2000โ‚น34.74